Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Medicine and Health Sciences
Plasma Glial Fibrillary Acidic Protein Is Associated With 18f-Smbt-1 Pet: Two Putative Astrocyte Reactivity Biomarkers For Alzheimer's Disease, Pratishtha Chatterjee, Vincent Doré, Steve Pedrini, Natasha Krishnadas, Rohith Thota, Pierrick Bourgeat, Milos D. Ikonomovic, Stephanie R. Rainey-Smith, Samantha C. Burnham, Christopher Fowler, Kevin Taddei, Rachel Mulligan, David Ames, Colin L. Masters, Jürgen Fripp, Christopher C. Rowe, Ralph N. Martins, Victor L. Villemagne, Aibl Research Group
Plasma Glial Fibrillary Acidic Protein Is Associated With 18f-Smbt-1 Pet: Two Putative Astrocyte Reactivity Biomarkers For Alzheimer's Disease, Pratishtha Chatterjee, Vincent Doré, Steve Pedrini, Natasha Krishnadas, Rohith Thota, Pierrick Bourgeat, Milos D. Ikonomovic, Stephanie R. Rainey-Smith, Samantha C. Burnham, Christopher Fowler, Kevin Taddei, Rachel Mulligan, David Ames, Colin L. Masters, Jürgen Fripp, Christopher C. Rowe, Ralph N. Martins, Victor L. Villemagne, Aibl Research Group
Research outputs 2022 to 2026
Background:
Astrocyte reactivity is an early event along the Alzheimer's disease (AD) continuum. Plasma glial fibrillary acidic protein (GFAP), posited to reflect astrocyte reactivity, is elevated across the AD continuum from preclinical to dementia stages. Monoamine oxidase-B (MAO-B) is also elevated in reactive astrocytes observed using 18F-SMBT-1 PET in AD.
Objective:
The objective of this study was to evaluate the association between the abovementioned astrocyte reactivity biomarkers.
Methods:
Plasma GFAP and Aβ were measured using the Simoa® platform in participants who underwent brain 18F-SMBT-1 and Aβ-PET imaging, comprising 54 healthy control (13 Aβ-PET+ and 41 Aβ-PET-), 11 …